
Lo mhlahlandlela obanzi ukusiza ukuthi uqonde ngokucacile i-renal cell carcinoma (sula i-renal cell carcinoma eduze kwami) bese uzulazula izinketho zakho zokwelashwa nokusekelwa. Sizohlola ukuxilongwa, izindlela zokwelapha, nezinsiza zokukusiza ukuthi uthole ukunakekelwa okungcono kakhulu eduze nasekhaya. Funda mayelana nentuthuko yakamuva futhi uthole izimpendulo zemibuzo yakho.
I-clear cell renal cell carcinoma (ccRCC) wuhlobo oluvame kakhulu lomdlavuza wezinso. Isuka olwelweni lwezinso futhi ingasakazekela kwezinye izingxenye zomzimba. Ukusheshe kutholakale kubalulekile ekwelapheni okuyimpumelelo. Izimpawu zingaba ezicashile, ngokuvamile ezihlanganisa igazi emchameni, ubuhlungu behlangothi, noma isisindo esizwakalayo. Uma uhlangabezana nanoma yikuphi kwalokhu, kubalulekile ukufuna usizo lwezokwelapha ngokushesha.
Ukuxilongwa kuvame ukubandakanya ukuhlolwa kwesithombe njenge-CT scans noma i-MRIs, kanye ne-biopsy ukuze kuqinisekiswe ukuxilongwa nokunquma isigaba somdlavuza. Isiteji sisiza ukunquma izinga lokusabalala komdlavuza futhi kuqondise izinqumo zokwelashwa. Isiteji esinembile sibalulekile ekubikezeleni isibikezelo nokukhetha uhlelo olufanele lokwelapha.
Ukuhlinzwa kuvame ukuba wukwelashwa okuyinhloko kwe-ccRCC yendawo. Lokhu kungase kuhlanganise i-nephrectomy engaphelele (ukususwa kwesimila nengxenye encane yezinso) noma i-radical nephrectomy (ukususwa kwayo yonke izinso). Okukhethwa kukho kuncike kusayizi nendawo yesimila, kanye nempilo yonke yesiguli.
Izindlela zokwelapha ezihlosiwe ziyimithi eqondise ngokuqondile amangqamuzana omdlavuza, enciphisa ukulimala kwamangqamuzana anempilo. Lezi zindlela zokwelapha ziguqule ukwelashwa kwe-ccRCC, zinikeza imiphumela ethuthukisiwe ezigulini eziningi. Izibonelo zifaka i-tyrosine kinase inhibitors (TKIs) njenge-sunitinib, pazopanib, ne-axitinib. I-oncologist yakho izonquma ukwelashwa okuhlosiwe okungcono kakhulu okusekelwe esimweni sakho esithile.
I-Immunotherapy ihlanganisa amandla amasosha omzimba ukulwa nomdlavuza. Ama-immune checkpoint inhibitors, njenge-nivolumab ne-ipilimumab, asetshenziselwa ukwelapha i-ccRCC ethuthukisiwe. Lezi zindlela zokwelapha zisebenza ngokuvimbela amaprotheni avimbela amasosha omzimba ekuhlaseleni amangqamuzana omdlavuza. Zisebenza kakhulu ezigulini ezithile.
Ukwelapha ngemisebe kusebenzisa imisebe enamandla amakhulu ukubulala amangqamuzana omdlavuza. Nakuba ngokuvamile kungeyona indlela yokwelapha eyinhloko ye-ccRCC, ingabamba iqhaza ekulawuleni izimpawu noma ekwelapheni izifo zasendaweni.
Ukubamba iqhaza ezivivinyweni zomtholampilo kunikeza ukufinyelela ekwelashweni okusha futhi kunomthelela entuthukweni ocwaningweni lomdlavuza. I-ClinicalTrials.gov (https://clinicaltrials.gov/) iyinsiza ebalulekile yokuthola izinhlolo zokwelashwa ezifanele sula i-renal cell carcinoma eduze kwami.
Ukuthola i-oncologist enekhono onguchwepheshe bomdlavuza wezinso kubaluleke kakhulu. Ungaqala usesho lwakho usebenzisa izinkomba ze-inthanethi noma ngokuthintana nodokotela wakho wokunakekela oyinhloko. Bheka odokotela abaxhumene nezikhungo zomdlavuza ezihlonishwayo. Cabangela izici ezifana nesipiliyoni, ubuchwepheshe ekwelashweni kwe-ccRCC, nokubuyekezwa kwesiguli.
Ukuze uthole ukunakekelwa okuphelele komdlavuza, cabanga ngokufuna ukwelashwa esikhungweni esikhethekile esifana ne- I-Shandong Baofa Cancer Research Institute. Banikeza amathuluzi okuxilonga athuthukile, izinketho zokwelapha ezisezingeni eliphezulu, kanye nethimba lezinhlaka eziningi ukuhlinzeka ngokunakekelwa komuntu siqu.
Ukuzulazula ekuxilongweni kwe-ccRCC kungaba inselele. Amaqembu okusekela, izinkundla ze-inthanethi, nezinhlangano ezimelela isiguli zinikeza izinsiza ezibalulekile kanye nomphakathi wabantu ababelana ngesipiliyoni esifanayo. I-American Cancer Society kanye neNational Cancer Institute inikeza ulwazi oluningi kanye nezinsizakalo zokusekela. Khumbula, awuwedwa kulolu hambo.
Lolu lwazi luhloselwe izinjongo zemfundo kuphela futhi akufanele luthathwe njengeseluleko sezokwelapha. Hlala uthintana nochwepheshe bezempilo abaqeqeshiwe ukuze uxilongwe futhi ulashwe noma yisiphi isimo sezempilo.
eceleni>